The Otsuka Patient Assistance Foundation, Inc. (OPAF) is a 501c(3) nonprofit organization that provides eligible uninsured or underinsured patients with prescribed Otsuka medication free of cost.
The OPAF mission is to improve the health & wellness for eligible patients by reducing barriers to healthy living and enabling patients along their health journeys.
For assistance, please contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am to 8pm ET, excluding National Holidays).
You can complete applications on behalf of patients with access barriers or those who are uninsured or underinsured. Apply online through the OPAF Care Connect Portal.
When you sign up for the OPAF Care Connect Portal, you can:
For states that require eScribe, please submit a prescription via your EMR system to:
Eversana Life Science Services, 17877 Chesterfield Airport Road, Chesterfield, MO 63005.
Phone: 1-855-727-6274
Fax: 1-844-727-6274
Hours: Monday to Friday, 8am to 8pm ET.
See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for , ABILIFY ASIMTUFII , JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for , ABILIFY ASIMTUFII , JYNARQUE, REXULTI, and SAMSCA.
For states that require eScribe, please submit a prescription via your EMR system to:
Eversana Life Science Services, 17877 Chesterfield Airport Road, Chesterfield, MO 63005.
Phone: 1-855-727-6274
Fax: 1-844-727-6274
Hours: Monday to Friday, 8am to 8pm ET.
See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA , ABILIFY ASIMTUFII , JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA , ABILIFY ASIMTUFII , JYNARQUE, REXULTI, and SAMSCA.
Enrollment Application for (aripiprazole) extended-release injectable suspension
Enrollment Application for (aripiprazole) extended-release injectable suspension
Enrollment Application for REXULTI ® (brexpiprazole) tablets
Enrollment Application for NUEDEXTA ® (dextromethorphan HBr and quinidine sulfate) capsules
Enrollment Application for SAMSCA ® (tolvaptan) tablets
Enrollment Application for JYNARQUE ® (tolvaptan) tablets
Enrollment Application for (aripiprazole) extended-release injectable suspension
Enrollment Application for (aripiprazole) extended-release injectable suspension
Enrollment Application for REXULTI ® (brexpiprazole) tablets
Enrollment Application for NUEDEXTA ® (dextromethorphan HBr and quinidine sulfate) capsules
Enrollment Application for SAMSCA ® (tolvaptan) tablets
Enrollment Application for JYNARQUE ® (tolvaptan) tablets
We encourage you to apply and let a dedicated Patient Access Advocate do an in-depth eligibility analysis for you. You can contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am to 8pm ET, excluding National Holidays) with questions.
APPLY ONLINE Frequently Asked Questions
If the Eligibility tool indicates that I may be eligible, can I submit an application?
Yes, you can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. When submitting your information into the portal, please be sure to upload all of the required documentation such as income verification, U.S. home address verification, and insurance denial information.
Send a secure message directly to a dedicated OPAF Patient Access Advocate.
OPAF provides eligible patients no-cost support for the following prescribed medications:
See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for , ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for , ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.
To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).
Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.
Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Access Advocate without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.
Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.
To setup your OPAF secure message account follow the steps below:
If you have any questions, please contact OPAF at 1-855-727-6274 8:00 AM - 8:00 PM ET.
Do you have a question about the Otsuka Patient Assistance Foundation, Inc. (OPAF)?
You may send a SECURE MESSAGE by using the "Message Us" red icon below. OPAF’s secure message platform is password protected and HIPAA complaint. Your message will be received, and our Patient Access Advocates will respond shortly.
If you would like to call OPAF and speak to a Patient Access Advocate, please call OPAF at Monday-Friday 8 AM-8 PM EST.
We are experiencing a higher volume of calls and there may be longer wait times as we help patients with their concerns.
